Yufeng Qian

24 papers receiving 394 citations

Peers

Yufeng Qian
Comparison fields: 5 of 81
  • Molecular Biology 117
  • Pulmonary and Respiratory Medicine 95
  • Public Health, Environmental and Occupational Health 63
  • Radiology, Nuclear Medicine and Imaging 55
  • Oncology 51
Replace Chiemi Sakai with:
Chiemi Sakai Japan
Martin Heidt Germany
Wagdi Elkashef Egypt
Ghassan M. Hammoud United States
Ahmet Kocael Türkiye
Nobuyuki Kita Japan
Seren Özeni̇rler Türkiye
Ebru Kale Türkiye
Yunzhi Chen China
Antonella Marcoccia Italy
Yufeng Qian relative to Chiemi Sakai Japan Chiemi Sakai's profile →
Citations per field
00.5×
Chiemi Sakai · 1×
Citations per year

Countries citing papers authored by Yufeng Qian

Since Specialization
Citations

This map shows the geographic impact of Yufeng Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Qian more than expected).

Fields of papers citing papers by Yufeng Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Qian. The network helps show where Yufeng Qian may publish in the future.

Co-authorship network of co-authors of Yufeng Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Qian. A scholar is included among the top collaborators of Yufeng Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Qian. Yufeng Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 0
5 2
6 0
7 3
8 9
9 13
10 10
11
A clinical trial for computed tomography myocardial perfusion based non-invasive index of microcirculatory resistance (MPBIMR): rationale and trial design.
2
12 8
13 49
14 1
15 56
16 17
17 20
18 79
19 79
20
Cancer risk and key components of metabolic syndrome: a population-based prospective cohort study in Chinese.
10

About Yufeng Qian

Yufeng Qian is a scholar working on Cancer Research, Hematology and Internal Medicine, having authored 31 papers that have together received 398 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Spondyloarthritis Studies and Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (95 citations), Radiology, Nuclear Medicine and Imaging (55 citations) and Biochemistry (14 citations). Yufeng Qian has collaborated with scholars based in China, Singapore and United Kingdom. Frequent co-authors include Peiwei Li, Xianhua Ye, Jun Yang, Yihua Wu, Jinjie Zhang, Geng Xu, Yu Shi, Han Wu, Chao Li and Honghe Zhang. Their work appears in journals such as International Journal of Cancer, Frontiers in Immunology and Frontiers in Psychology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026